November 4, 2021
Otsuka Pharmaceutical said on November 2 that its in-vitro diagnostic “minor BCR-ABL mRNA measurement kit” is now covered by Japanese health insurance, making it the first marker tool to monitor treatment effectiveness for acute lymphoblastic leukemia (ALL). The product was...read more